Eligibility for Substance Use Clinical Trials Among Emergency Psychiatry Patients: The Impact of Exclusion Criteria

被引:0
|
作者
Lawrence, Ryan E. [1 ]
Bernstein, Adam [2 ]
Jaffe, Chaya [3 ]
Zhao, Yinjun [4 ]
Wang, Yuanjia [5 ]
Goldberg, Terry E. [6 ]
机构
[1] Columbia Univ, Med Ctr, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA
[2] Creedmoor Psychiat Ctr, Queens, NY USA
[3] New York State Psychiat Inst & Hosp, New York, NY USA
[4] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA
[5] Columbia Univ, Dept Biostat, New York, NY USA
[6] Columbia Univ, Med Ctr, Dept Med Psychol Psychiat, New York, NY USA
关键词
Clinical trial; inclusion criteria; exclusion criteria; eligibility; internal validity; external validity; ALCOHOL DEPENDENCE; GENERALIZABILITY; EFFICACY; INELIGIBILITY; PARTICIPANTS; TOOL;
D O I
10.1080/15504263.2024.2377100
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The first objective was to identify common exclusion criteria used in clinical trials. The second objective was to quantify the degree to which these criteria exclude emergency psychiatry patients. Methods: Qualitative Content Analysis was used for the first objective, identifying common exclusion criteria used in recent high-impact substance use clinical trials. A retrospective record review was used for the second objective, which examined the frequency of these exclusion criteria in a 1-month sample of adults receiving psychiatric evaluation in an emergency department. Results: Most trials had exclusions for co-occurring psychiatric problems (76.6%), medical problems (74.0%), prior or current treatment (72.7%), motivation for change (61.1%), pregnancy or lactation (57.1%), or using other specified substances of abuse (54.6%). In the clinical sample, exclusions for co-occurring psychiatric problems would make 94.7% of patients ineligible. Other exclusions had a combined effect of making 76% of patients ineligible. Conclusions: Clinical trials using typical exclusion criteria exclude nearly all emergency psychiatry patients with substance use problems.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Inclusion and Exclusion Criteria of Clinical Trials for Insomnia
    Huls, Hendrikje
    Abdulahad, Smedra
    Mackus, Marlou
    van de Loo, Aurora J. A. E.
    Roehrs, Timothy
    Roth, Thomas
    Verster, Joris C.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (08)
  • [22] Substance use and homelessness among emergency department patients
    Doran, Kelly M.
    Rahai, Neloufar
    McCormack, Ryan P.
    Milian, Jacqueline
    Shelley, Donna
    Rotrosen, John
    Gelberg, Lillian
    DRUG AND ALCOHOL DEPENDENCE, 2018, 188 : 328 - 333
  • [23] Impact of renal function eligibility criteria in clinical trials and real-world survival outcomes among patients with metastatic renal cell carcinoma.
    Miron, Benjamin
    Wang, Xiaoliang
    Hasler, Jill S.
    Royce, Trevor Joseph
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 407 - 407
  • [24] A systematic review of eligibility criteria for phase II clinical trials for patients with lung cancer
    Doherty, Gary
    Ogunmwonyi, Innocent
    Shotton, Rohan
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 46 - 46
  • [25] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Szlezinger, Katarzyna
    Pogoda, Katarzyna
    Jagiello-Gruszfeld, Agnieszka
    Klosowska, Danuta
    Gorski, Andrzej
    Borysowski, Jan
    BMC MEDICINE, 2023, 21 (01)
  • [27] Eligibility for inclusion criteria in use for rheumatoid arthritis (RA) clinical trials in a Turkish cohort.
    Gogus, F
    Yazici, Y
    Yazici, H
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S128 - S128
  • [28] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Katarzyna Szlezinger
    Katarzyna Pogoda
    Agnieszka Jagiełło-Gruszfeld
    Danuta Kłosowska
    Andrzej Górski
    Jan Borysowski
    BMC Medicine, 21
  • [29] Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia
    Hantel, Andrew
    Luskin, Marlise R.
    Khan, Irum
    Warner, Elizabeth
    Patel, Anand A.
    Walsh, Thomas P.
    Deangelo, Daniel J.
    Lathan, Christopher S.
    Abel, Gregory A.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1046 - 1052
  • [30] Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia
    Hantel, Andrew
    Luskin, Marlise R.
    Khan, Irum
    Warner, Elizabeth
    Patel, Anand A.
    Walsh, Thomas P.
    DeAngelo, Daniel J.
    Lathan, Christopher S.
    Abel, Gregory A.
    HAEMATOLOGICA, 2024, 109 (04) : 1046 - 1052